Four anti‐LGI1 patients had tumors: 1 patient had lung cancer, 1 colon adenocarcinoma, 1 renal cell carcinoma, and 1 rectal adenocarcinoma. This evidence concerns the gene LGI1 and rectum adenocarcinoma.